Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Oct. 31, 2022

A summary of the effect of the corrections on the condensed consolidated statements of operations for the three and nine months ended October 31, 2021 were as follows (in thousands, except per share data):


	Three Months Ended October 31, 2021						Nine Months Ended October 31, 2021
	As reported		Corrections		As Adjusted		As reported		Corrections		As Adjusted
Operating expenses:
Research and development	$	16,621	$	(30)	$	16,591	$	44,836	$	(119)	$	44,717
Sales and marketing	76,191		(1,493)		74,698		207,079		(2,506)		204,573
Total operating expenses	114,645		(1,523)		113,122		315,279		(2,625)		312,654
Operating loss	(26,289)		1,523		(24,766)		(66,299)		2,625		(63,674)
Loss before provision for income taxes	(27,408)		1,523		(25,885)		(71,043)		2,625		(68,418)
Net loss	(29,231)		1,523		(27,708)		(77,175)		2,625		(74,550)


Net loss per share attributable to Class A and Class B stockholders, basic and diluted	$	(0.11)	$	—	$	(0.11)	$	(0.44)	$	0.01	$	(0.43)

A summary of the effect of the corrections on the condensed consolidated statements of cash flows for the nine months ended October 31, 2021 were as follows (in thousands):


	Nine Months Ended October 31, 2021
	As reported	Corrections	As Adjusted

Net loss	(77,175)	2,625	(74,550)
Changes in operating assets and liabilities
Prepaid expenses and other current assets	(1,104)	(1,291)	(2,395)
Other non-current assets	(1,817)	(1,334)	(3,151)